QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)
QQQ   416.58 (-1.61%)
AAPL   165.24 (-1.08%)
MSFT   400.69 (-0.89%)
META   482.49 (-3.85%)
GOOGL   153.89 (-1.36%)
AMZN   174.97 (-2.37%)
TSLA   148.16 (-1.18%)
NVDA   792.58 (-6.39%)
AMD   148.15 (-4.47%)
NIO   3.83 (-4.25%)
BABA   69.03 (+0.22%)
T   16.45 (+0.73%)
F   12.11 (+0.41%)
MU   107.33 (-4.11%)
GE   148.98 (-2.59%)
CGC   8.02 (+2.43%)
DIS   112.39 (-0.04%)
AMC   3.18 (+8.90%)
PFE   25.88 (+1.93%)
PYPL   62.09 (-0.02%)
XOM   119.91 (+1.17%)

Cambridge Cognition (COG) Competitors

GBX 51.30
-0.70 (-1.35%)
(As of 11:44 AM ET)

COG vs. FDBK, INHC, RENX, OBD, OBI, OPTI, SBTX, VRCI, IHC, and NSCI

Should you be buying Cambridge Cognition stock or one of its competitors? The main competitors of Cambridge Cognition include Feedback (FDBK), Induction Healthcare Group (INHC), Renalytix (RENX), Oxford BioDynamics (OBD), Ondine Biomedical (OBI), OptiBiotix Health (OPTI), SkinBioTherapeutics (SBTX), Verici Dx (VRCI), Inspiration Healthcare Group (IHC), and NetScientific (NSCI). These companies are all part of the "medical" sector.

Cambridge Cognition vs.

Cambridge Cognition (LON:COG) and Feedback (LON:FDBK) are both small-cap medical companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation, community ranking and media sentiment.

Feedback has lower revenue, but higher earnings than Cambridge Cognition. Cambridge Cognition is trading at a lower price-to-earnings ratio than Feedback, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cambridge Cognition£12.77M1.40-£3.74M-£0.11-466.36
Feedback£1.02M14.38-£3.49M-£0.26-423.08

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Cambridge Cognition
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
Feedback
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Feedback has a net margin of 0.00% compared to Cambridge Cognition's net margin of -29.25%. Feedback's return on equity of -32.67% beat Cambridge Cognition's return on equity.

Company Net Margins Return on Equity Return on Assets
Cambridge Cognition-29.25% -630.55% -13.31%
Feedback N/A -32.67%-21.47%

Feedback received 60 more outperform votes than Cambridge Cognition when rated by MarketBeat users. Likewise, 67.07% of users gave Feedback an outperform vote while only 44.30% of users gave Cambridge Cognition an outperform vote.

CompanyUnderperformOutperform
Cambridge CognitionOutperform Votes
105
44.30%
Underperform Votes
132
55.70%
FeedbackOutperform Votes
165
67.07%
Underperform Votes
81
32.93%

36.6% of Cambridge Cognition shares are held by institutional investors. Comparatively, 52.8% of Feedback shares are held by institutional investors. 28.4% of Cambridge Cognition shares are held by insiders. Comparatively, 11.0% of Feedback shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

In the previous week, Cambridge Cognition had 5 more articles in the media than Feedback. MarketBeat recorded 5 mentions for Cambridge Cognition and 0 mentions for Feedback. Feedback's average media sentiment score of 0.00 beat Cambridge Cognition's score of -0.19 indicating that Feedback is being referred to more favorably in the news media.

Company Overall Sentiment
Cambridge Cognition Neutral
Feedback Neutral

Cambridge Cognition has a beta of 0.76, meaning that its stock price is 24% less volatile than the S&P 500. Comparatively, Feedback has a beta of 0.79, meaning that its stock price is 21% less volatile than the S&P 500.

Summary

Feedback beats Cambridge Cognition on 10 of the 15 factors compared between the two stocks.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COG and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

COG vs. The Competition

MetricCambridge CognitionHealth Information Services IndustryMedical SectorLON Exchange
Market Cap£17.93M£229.62M£4.80B£1.37B
Dividend YieldN/A6.24%2.92%12.07%
P/E Ratio-466.36607.24201.791,729.61
Price / Sales1.40705.812,475.09314,671.24
Price / Cash4.3138.9346.8832.96
Price / Book17.106.114.552.51
Net Income-£3.74M-£5.28M£103.81M£180.40M
7 Day Performance-1.35%0.88%-4.16%-1.00%
1 Month Performance-7.57%-4.29%-5.76%7.38%
1 Year Performance-47.33%-1.90%6.75%15.92%

Cambridge Cognition Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
FDBK
Feedback
0 of 5 stars
GBX 120
-4.0%
N/A-21.3%£16.00M£1.02M-461.5424News Coverage
Gap Down
INHC
Induction Healthcare Group
0 of 5 stars
GBX 13.50
-3.6%
N/A-36.7%£12.47M£11.82M-90.0083Gap Down
RENX
Renalytix
0 of 5 stars
GBX 29.21
+0.7%
N/A-68.8%£35.03M£2.41M-81.14102Gap Up
OBD
Oxford BioDynamics
0 of 5 stars
GBX 8.84
+0.9%
N/A-41.9%£17.89M£176,000.00-126.3345Gap Up
OBI
Ondine Biomedical
0 of 5 stars
GBX 7.81
+15.7%
N/A-60.9%£17.71M£856,000.00-130.17N/AGap Up
OPTI
OptiBiotix Health
0 of 5 stars
GBX 19.27
+0.1%
N/A+73.8%£17.57M£1.26M-128.479
SBTX
SkinBioTherapeutics
0 of 5 stars
GBX 9.84
+3.6%
N/A-45.3%£18.97M£21,949.00-492.0011
VRCI
Verici Dx
0 of 5 stars
GBX 8
-1.2%
N/A-37.6%£19.40MN/A-160.0014
IHC
Inspiration Healthcare Group
0 of 5 stars
GBX 28.90
+0.3%
N/A-43.1%£19.72M£41.08M-2,890.00210
NSCI
NetScientific
0 of 5 stars
GBX 65.30
+0.5%
N/A-25.5%£15.64M£1.38M-502.3126

Related Companies and Tools

This page (LON:COG) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners